메뉴 건너뛰기




Volumn 164, Issue 5, 2012, Pages 728-734

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients - Results from the PLATelet inhibition and patient Outcomes (PLATO) study

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; CREATININE; CYSTATIN C; TICAGRELOR; TROPONIN I;

EID: 84868602984     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.08.017     Document Type: Article
Times cited : (9)

References (24)
  • 1
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group
    • A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
    • (1999) Ann Intern Med , vol.130 , Issue.6 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3
  • 2
    • 65649142017 scopus 로고    scopus 로고
    • A new equation to estimate glomerular filtration rate
    • A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
    • (2009) Ann Intern Med , vol.150 , Issue.9 , pp. 604-612
    • Levey, A.S.1    Stevens, L.A.2    Schmid, C.H.3
  • 3
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
    • (1976) Nephron , vol.16 , Issue.1 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 4
    • 84856158305 scopus 로고    scopus 로고
    • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
    • M. Authors/Task Force, C.W. Hamm, and J.P. Bassand ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 23 2011 2999 3054
    • (2011) Eur Heart J , vol.32 , Issue.23 , pp. 2999-3054
    • Hamm, C.W.1    Bassand, J.P.2
  • 5
    • 0026442320 scopus 로고
    • Serum creatinine as an index of renal function: New insights into old concepts
    • R.D. Perrone, N.E. Madias, and A.S. Levey Serum creatinine as an index of renal function: new insights into old concepts Clin Chem 38 10 1992 1933 1953
    • (1992) Clin Chem , vol.38 , Issue.10 , pp. 1933-1953
    • Perrone, R.D.1    Madias, N.E.2    Levey, A.S.3
  • 6
    • 0034564507 scopus 로고    scopus 로고
    • Cystatin C - Properties and use as diagnostic marker
    • A.O. Grubb Cystatin C - properties and use as diagnostic marker Adv Clin Chem 35 2000 63 99
    • (2000) Adv Clin Chem , vol.35 , pp. 63-99
    • Grubb, A.O.1
  • 7
    • 0036228259 scopus 로고    scopus 로고
    • Cystatin C: An improved estimator of glomerular filtration rate?
    • O.F. Laterza, C.P. Price, and M.G. Scott Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48 5 2002 699 707
    • (2002) Clin Chem , vol.48 , Issue.5 , pp. 699-707
    • Laterza, O.F.1    Price, C.P.2    Scott, M.G.3
  • 8
    • 70449727926 scopus 로고    scopus 로고
    • Cystatin C and cardiovascular risk
    • N. Taglieri, W. Koenig, and J.C. Kaski Cystatin C and cardiovascular risk Clin Chem 55 11 2009 1932 1943
    • (2009) Clin Chem , vol.55 , Issue.11 , pp. 1932-1943
    • Taglieri, N.1    Koenig, W.2    Kaski, J.C.3
  • 9
    • 4644221457 scopus 로고    scopus 로고
    • Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    • A.S. Go, G.M. Chertow, and D. Fan Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
    • (2004) N Engl J Med , vol.351 , Issue.13 , pp. 1296-1305
    • Go, A.S.1    Chertow, G.M.2    Fan, D.3
  • 10
    • 1642545149 scopus 로고    scopus 로고
    • Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
    • E.L. Knight, J.C. Verhave, and D. Spiegelman Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int 65 4 2004 1416 1421
    • (2004) Kidney Int , vol.65 , Issue.4 , pp. 1416-1421
    • Knight, E.L.1    Verhave, J.C.2    Spiegelman, D.3
  • 11
    • 68049116349 scopus 로고    scopus 로고
    • Cystatin C - A paradigm of evidence based laboratory medicine
    • J.S. Chew, M. Saleem, and C.M. Florkowski Cystatin C - a paradigm of evidence based laboratory medicine Clin Biochem Rev 29 2 2008 47 62
    • (2008) Clin Biochem Rev , vol.29 , Issue.2 , pp. 47-62
    • Chew, J.S.1    Saleem, M.2    Florkowski, C.M.3
  • 12
    • 6444224408 scopus 로고    scopus 로고
    • Cystatin C: A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome
    • T. Jernberg, B. Lindahi, and S. James Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome Circulation 110 16 2004 2342 2348
    • (2004) Circulation , vol.110 , Issue.16 , pp. 2342-2348
    • Jernberg, T.1    Lindahi, B.2    James, S.3
  • 13
    • 84856075643 scopus 로고    scopus 로고
    • Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-Elevation and Non-ST-Elevation acute coronary syndromes: Results from the platelet inhibition and patient outcomes study
    • A. Akerblom, L. Wallentin, and A. Siegbahn Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-Elevation and Non-ST-Elevation acute coronary syndromes: results from the platelet inhibition and patient outcomes study Clin Chem 58 1 2012 190 199
    • (2012) Clin Chem , vol.58 , Issue.1 , pp. 190-199
    • Akerblom, A.1    Wallentin, L.2    Siegbahn, A.3
  • 14
    • 66549090699 scopus 로고    scopus 로고
    • Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T
    • F. Windhausen, A. Hirsch, and J. Fischer Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T Clin Chem 55 6 2009 1118 1125
    • (2009) Clin Chem , vol.55 , Issue.6 , pp. 1118-1125
    • Windhausen, F.1    Hirsch, A.2    Fischer, J.3
  • 15
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • L. Wallentin, RC. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 11 2009 1045 1057
    • (2009) N Engl J Med , vol.361 , Issue.11 , pp. 1045-1057
    • Wallentin, L.1    Becker, R.C.2    Budaj, A.3
  • 16
    • 62949141274 scopus 로고    scopus 로고
    • Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
    • S. James, A. Akerblom, and C.P. Cannon Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 157 4 2009 599 605
    • (2009) Am Heart J , vol.157 , Issue.4 , pp. 599-605
    • James, S.1    Akerblom, A.2    Cannon, C.P.3
  • 17
    • 0023710206 scopus 로고
    • Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
    • E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 3 1988 837 845
    • (1988) Biometrics , vol.44 , Issue.3 , pp. 837-845
    • Delong, E.R.1    Delong, D.M.2    Clarke-Pearson, D.L.3
  • 18
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • [discussion 207-12]
    • M.J. Pencina, R.B. Sr. D'Agostino, and R.B. Jr. D'Agostino Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 2008 157 172 [discussion 207-12]
    • (2008) Stat Med , vol.27 , Issue.2 , pp. 157-172
    • Pencina, M.J.1    D'Agostino, R.B.Sr.2    D'agostino Jr., R.B.3
  • 19
    • 77957270303 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
    • S. James, A. Budaj, and P. Aylward Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 122 11 2010 1056 1067
    • (2010) Circulation , vol.122 , Issue.11 , pp. 1056-1067
    • James, S.1    Budaj, A.2    Aylward, P.3
  • 20
    • 18644370841 scopus 로고    scopus 로고
    • Cystatin C and the risk of death and cardiovascular events among elderly persons
    • M.G. Shlipak, M.J. Sarnak, and R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060
    • (2005) N Engl J Med , vol.352 , Issue.20 , pp. 2049-2060
    • Shlipak, M.G.1    Sarnak, M.J.2    Katz, R.3
  • 21
    • 61349147106 scopus 로고    scopus 로고
    • Factors other than glomerular filtration rate affect serum cystatin C levels
    • L.A. Stevens, C.H. Schmid, and T. Greene Factors other than glomerular filtration rate affect serum cystatin C levels Kidney Int 75 6 2009 652 660
    • (2009) Kidney Int , vol.75 , Issue.6 , pp. 652-660
    • Stevens, L.A.1    Schmid, C.H.2    Greene, T.3
  • 23
    • 0034642827 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
    • G.L. Bakris, and M.R. Weir Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160 5 2000 685 693
    • (2000) Arch Intern Med , vol.160 , Issue.5 , pp. 685-693
    • Bakris, G.L.1    Weir, M.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.